Solumedrol
Solumedrol is a pharmaceutical drug with 16 clinical trials. Currently 3 active trials ongoing. Historical success rate of 81.8%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
9
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
9 of 11 finished
18.2%
2 ended early
3
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
Clinical Trials (16)
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Allogeneic Transplantation From Related Haploidentical Donors
Corticosteroid Pulse After Ablation
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16